HK1207825A1 - Freeze-dried preparation containing high-purity pth and method for producing same pth - Google Patents

Freeze-dried preparation containing high-purity pth and method for producing same pth

Info

Publication number
HK1207825A1
HK1207825A1 HK15108506.3A HK15108506A HK1207825A1 HK 1207825 A1 HK1207825 A1 HK 1207825A1 HK 15108506 A HK15108506 A HK 15108506A HK 1207825 A1 HK1207825 A1 HK 1207825A1
Authority
HK
Hong Kong
Prior art keywords
pth
freeze
preparation containing
containing high
producing same
Prior art date
Application number
HK15108506.3A
Other languages
English (en)
Chinese (zh)
Inventor
西尾文秀
前島卓治
三留佳郎
Original Assignee
Asahi Kasei Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47296001&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1207825(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asahi Kasei Pharma Corp filed Critical Asahi Kasei Pharma Corp
Publication of HK1207825A1 publication Critical patent/HK1207825A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B55/00—Preserving, protecting or purifying packages or package contents in association with packaging
    • B65B55/02—Sterilising, e.g. of complete packages
    • B65B55/04—Sterilising wrappers or receptacles prior to, or during, packaging
    • B65B55/10—Sterilising wrappers or receptacles prior to, or during, packaging by liquids or gases
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B55/00—Preserving, protecting or purifying packages or package contents in association with packaging
    • B65B55/02—Sterilising, e.g. of complete packages
    • B65B55/12—Sterilising contents prior to, or during, packaging
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B63/00—Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged
    • B65B63/08—Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged for heating or cooling articles or materials to facilitate packaging
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mechanical Engineering (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • General Engineering & Computer Science (AREA)
HK15108506.3A 2011-06-07 2015-09-01 Freeze-dried preparation containing high-purity pth and method for producing same pth HK1207825A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011127698 2011-06-07

Publications (1)

Publication Number Publication Date
HK1207825A1 true HK1207825A1 (en) 2016-02-12

Family

ID=47296001

Family Applications (3)

Application Number Title Priority Date Filing Date
HK14103239.9A HK1190304A1 (zh) 2011-06-07 2014-04-03 高純度含 冷凍乾燥製劑及其製造方法
HK15108506.3A HK1207825A1 (en) 2011-06-07 2015-09-01 Freeze-dried preparation containing high-purity pth and method for producing same pth
HK18116438.6A HK1257291A1 (zh) 2011-06-07 2018-12-21 含pth肽冷凍干燥製劑的檢査方法及包含該含pth肽冷凍干燥製劑的醫藥品的製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK14103239.9A HK1190304A1 (zh) 2011-06-07 2014-04-03 高純度含 冷凍乾燥製劑及其製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK18116438.6A HK1257291A1 (zh) 2011-06-07 2018-12-21 含pth肽冷凍干燥製劑的檢査方法及包含該含pth肽冷凍干燥製劑的醫藥品的製造方法

Country Status (8)

Country Link
US (3) US20140088014A1 (xx)
EP (3) EP3170493B1 (xx)
JP (12) JPWO2012169435A1 (xx)
KR (6) KR101891673B1 (xx)
CN (3) CN104645318B (xx)
ES (3) ES2833535T3 (xx)
HK (3) HK1190304A1 (xx)
WO (1) WO2012169435A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104645318B (zh) * 2011-06-07 2021-11-02 旭化成制药株式会社 高纯度含pth冷冻干燥制剂及其制造方法
WO2013086217A1 (en) 2011-12-06 2013-06-13 Masco Corporation Of Indiana Ozone distribution in a faucet
CN115093008B (zh) 2015-12-21 2024-05-14 德尔塔阀门公司 包括消毒装置的流体输送系统
KR102606317B1 (ko) 2016-06-02 2023-11-23 에스케이온 주식회사 리튬 이차 전지용 음극 활물질, 이를 포함하는 음극 및 리튬 이차 전지
CA3167644A1 (en) 2017-09-22 2019-03-28 Asahi Kasei Pharma Corporation Teriparatide-containing liquid pharmaceutical composition having excellent pharmacokinetics and/or safety
CA3075977A1 (en) * 2017-09-22 2019-03-28 Asahi Kasei Pharma Corporation Teriparatide-containing liquid pharmaceutical composition having excellent stability
CN110917150A (zh) * 2019-12-31 2020-03-27 北京博康健基因科技有限公司 一种pth冻干制剂及其制备方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK137287B (da) 1970-08-25 1978-02-13 Atlas As Frysetørringsapparat.
JPS5568572A (en) 1978-11-16 1980-05-23 Ishikawajima Harima Heavy Ind Method of and apparatus for drying waterrcontaining article having oxidizability
JPS55112980A (en) 1979-02-26 1980-09-01 Nippon Oxygen Co Ltd Freezing drier
JPS5671931A (en) 1979-11-19 1981-06-15 Canon Inc Film formation
JPS6267099A (ja) * 1985-09-19 1987-03-26 Toyo Jozo Co Ltd 〔Ｎｌｅｂ，２１，〕−ｒ−ＰＴＨ（１−３４）ペプチド誘導体
JPH0116799Y2 (xx) 1986-02-05 1989-05-17
JPS6360904A (ja) 1986-08-29 1988-03-17 Yoshiaki Matsuo 農作物等植物栽培用生育促進補助水
JPS6360940A (ja) 1986-09-01 1988-03-17 Toyo Jozo Co Ltd 白内障の予防または治療剤
JP2505812B2 (ja) 1987-07-10 1996-06-12 旭化成工業株式会社 ｈ―ＰＴＨ（１―３４）凍結乾燥組成物
US5059587A (en) 1987-08-03 1991-10-22 Toyo Jozo Company, Ltd. Physiologically active peptide composition for nasal administration
JPH02111A (ja) 1987-08-03 1990-01-05 Toyo Jozo Co Ltd 経鼻投与用生理活性ペプチド製剤
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
US5208041A (en) * 1991-05-23 1993-05-04 Allelix Biopharmaceuticals Inc. Essentially pure human parathyroid hormone
ES2160591T3 (es) * 1991-12-06 2001-11-16 Genentech Inc Celulas transformadas por convertasas prohormonales.
KR0131678B1 (ko) 1991-12-09 1998-04-17 유미꾸라 레이이찌 파라티로이드 호르몬류의 안정화 조성물
JP2662842B2 (ja) 1991-12-09 1997-10-15 旭化成工業株式会社 パラサイロイドホルモンの安定化組成物
US5496801A (en) * 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
JPH0873376A (ja) 1994-09-07 1996-03-19 Asahi Chem Ind Co Ltd 骨粗鬆症治療薬
DE19538687A1 (de) 1995-10-17 1997-04-24 Boehringer Mannheim Gmbh Stabile pharmazeutische Darreichungsformen enthaltend Parathormon
SE9801495D0 (sv) * 1998-04-28 1998-04-28 Astra Ab Protein formulationa
AR033639A1 (es) 1998-08-19 2004-01-07 Lilly Co Eli Uso de hormonas paratiroideas para preparar medicamentos para reducir el riesgo de fracturas oseas vertebrales o no vertebrales en seres humanos con riesgo de padecer o que padecen osteoporosis
EP1221966B1 (en) * 1999-09-20 2005-11-16 Eli Lilly And Company Use of a parathyroid hormone for reducing the risk of cancer
ES2343124T3 (es) * 1999-10-29 2010-07-23 Novartis Ag Composiciones de polvo seco con dispersabilidad mejorada.
AU6788701A (en) * 2000-06-30 2002-01-14 Suntory Ltd Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components
US6838264B2 (en) * 2000-12-05 2005-01-04 Immutopics, Inc. Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
JP4931306B2 (ja) 2001-09-27 2012-05-16 旭化成ファーマ株式会社 骨形成を安全に促進させる医薬複合剤
BRPI0509788A (pt) * 2004-05-13 2007-10-23 Alza Corp aparato e método para liberação transdérmica de agentes de hormÈnio paratireóides
CN101132775A (zh) 2005-03-14 2008-02-27 惠氏公司 替加环素组合物及制备方法
EP1986674A4 (en) * 2006-02-13 2009-11-11 Nektar Therapeutics PROTEIN OR PEPTIDE COMPOSITIONS PROTEIN CONTAINING METHIONINE AND METHOD FOR MANUFACTURING AND USING SAME
CN1861790A (zh) * 2006-04-25 2006-11-15 华东理工大学 重组人甲状旁腺激素1－84的制备方法
PT2034951E (pt) * 2006-06-22 2013-04-18 Biocompatibles Uk Ltd Produto farmacêutico reidratável
BRPI0719821B8 (pt) * 2006-10-03 2021-05-25 Ipsen Pharma Sas composição estável na armazenagem apropriada para administração a pacientes
DK2089645T3 (da) * 2006-11-07 2013-03-04 Ima Life North America Inc Frysetørrerbarrieresystem
EP2106788A1 (en) 2008-04-04 2009-10-07 Ipsen Pharma Liquid and freeze dried formulations
JP5705115B2 (ja) 2008-09-10 2015-04-22 ジェネンテック， インコーポレイテッド 蛋白質の酸化的分解の予防のための組成物および方法
CN102216214A (zh) 2008-11-18 2011-10-12 伯卢·拉维·克里希纳 用于将固体有机材料转化为碳或活性碳的方法和装置
JP5253246B2 (ja) * 2009-03-12 2013-07-31 株式会社アルバック 凍結真空乾燥装置
CN104645318B (zh) * 2011-06-07 2021-11-02 旭化成制药株式会社 高纯度含pth冷冻干燥制剂及其制造方法
JP6416799B2 (ja) 2016-01-19 2018-10-31 株式会社ユニバーサルエンターテインメント 遊技機

Also Published As

Publication number Publication date
KR20170064558A (ko) 2017-06-09
CN104645318A (zh) 2015-05-27
CN108195965A (zh) 2018-06-22
KR20160068987A (ko) 2016-06-15
ES2833535T3 (es) 2021-06-15
JP5960935B2 (ja) 2016-08-02
JP2015096548A (ja) 2015-05-21
JP2016222710A (ja) 2016-12-28
JP2016179999A (ja) 2016-10-13
JP2017019865A (ja) 2017-01-26
CN104645318B (zh) 2021-11-02
JP6258426B2 (ja) 2018-01-10
EP3020409A1 (en) 2016-05-18
JP6031633B1 (ja) 2016-11-24
US10011643B2 (en) 2018-07-03
KR20150116468A (ko) 2015-10-15
US20180265561A1 (en) 2018-09-20
EP3170493A1 (en) 2017-05-24
ES2833277T3 (es) 2021-06-14
JP6025881B2 (ja) 2016-11-16
JP6038374B2 (ja) 2016-12-07
JP2016130254A (ja) 2016-07-21
JP6153237B2 (ja) 2017-06-28
JP2016014042A (ja) 2016-01-28
KR101787956B1 (ko) 2017-10-18
EP3020409B1 (en) 2019-10-09
WO2012169435A1 (ja) 2012-12-13
CN103561757B (zh) 2016-01-06
US20160145316A1 (en) 2016-05-26
HK1190304A1 (zh) 2014-07-04
JP2016172765A (ja) 2016-09-29
EP2719393B1 (en) 2020-10-21
KR20170063998A (ko) 2017-06-08
EP2719393A4 (en) 2015-04-08
EP2719393A1 (en) 2014-04-16
JP5996824B1 (ja) 2016-09-21
JP2017008099A (ja) 2017-01-12
ES2761635T3 (es) 2020-05-20
US20140088014A1 (en) 2014-03-27
CN108195965B (zh) 2021-02-23
JP2018058883A (ja) 2018-04-12
KR20150116467A (ko) 2015-10-15
KR20140001255A (ko) 2014-01-06
JPWO2012169435A1 (ja) 2015-02-23
JP5922833B2 (ja) 2016-05-24
JP2017025088A (ja) 2017-02-02
KR101792473B1 (ko) 2017-10-31
HK1257291A1 (zh) 2019-10-18
KR101891673B1 (ko) 2018-08-27
CN103561757A (zh) 2014-02-05
US10683335B2 (en) 2020-06-16
JP2016172766A (ja) 2016-09-29
EP3170493B1 (en) 2020-10-21
JP6057492B1 (ja) 2017-01-11

Similar Documents

Publication Publication Date Title
EP2902435A4 (en) PREPREG AND METHOD FOR THE PRODUCTION THEREOF
EP2740771C0 (en) COMPOSITE POWDER AND METHOD OF MANUFACTURE THEREOF
EP2692423A4 (en) DEVICE FOR PREPARING COMPOSITE PARTICLES AND METHOD FOR PRODUCING COMPOSITE PARTICLES
EP2743232A4 (en) POROUS STRUCTURE AND METHOD FOR MANUFACTURING THE SAME
EP2894190A4 (en) PRE-IMPREGNATED AND METHOD FOR PRODUCING THE SAME
EP2763933A4 (en) PROCESS FOR THE PREPARATION AND USE OF NANOPARTICLES
EP2679099A4 (en) CHOCOLATES AND METHOD FOR THEIR MANUFACTURE
EP2689670A4 (en) MEAT INSERT AND MANUFACTURING METHOD THEREFOR
HK1207825A1 (en) Freeze-dried preparation containing high-purity pth and method for producing same pth
EP2548868A4 (en) METHOD FOR PRODUCING DEUTERATED OMEGA DIPHENYL UREA
SG11201400744XA (en) Self-assembled nano-structure particle and method for preparing
GB2509677B (en) Method for producing medical oversleeves and production system
EP2907790A4 (en) METHOD FOR PRODUCING NANO CARBON FILMS AND NANO CARBON FILM
EP2781247A4 (en) POWDER DISCOVERERS AND METHOD FOR THE PRODUCTION THEREOF
EP2671637A4 (en) DEVICE FOR PREPARING A MIXING SOLUTION AND METHOD FOR PRODUCING A MIXING SOLUTION
EP2781485A4 (en) HOLLOW NANOPARTICLES, AND METHOD FOR MANUFACTURING SAME
SG10201604976RA (en) Hydroxy-aminopolymers and method for producing same
EP2853370A4 (en) COMPOSITE BODY AND METHOD FOR PRODUCING THE COMPOSITE BODY
SG11201400909WA (en) Composition and method for producing same
EP2738776A4 (en) TRANSPARENT CONDUCTOR AND METHOD FOR MANUFACTURING THE SAME
EP2610338A4 (en) PROCESS FOR PRODUCTION OF SUBSTANCE
EP2698159A4 (en) PITAVASTATE-CONTAINING PREPARATION AND METHOD OF MANUFACTURING THEREOF
EP2844382A4 (en) PARTICLES AND METHOD FOR PRODUCING PARTICLES
EP2690064A4 (en) INORGANIC COMPOUND PARTICLES AND METHOD FOR PRODUCING THE SAME
EP2742997A4 (en) VEHICLE FOR ADSORPTION AND METHOD FOR PRODUCING THE SAME